References: Saner FH, Stueben B-O, Hoyer DP, et al.: Use or misuse of albumin in critical ill patients. Diseases. 2023; 11:68.
Finfer S, Bellomo R, Boyce N, et al.; SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350:2247–2256.
Caironi P, Tognoni G, Masson S, et al.; ALBIOS Study Investigators: Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014; 370:1412–1421.
Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. BMJ. 1998; 317:235–240.
Finfer S, Bellomo R, et al.; SAFE Study Investigators: Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: Analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ. 2006; 333:1044.
Patel A, Laffan MA, Waheed U, et al.: Randomised trials of human albumin for adults with sepsis: Systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014; 349:g4561.
Geng L, Tian X, Gao Z, et al.: Different concentrations of albumin versus crystalloid in patients with sepsis and septic shock: A meta-analysis of randomized clinical trials. J Intensive Care Med. 2023; 38:679–689.
Zou Y, Ma K, Xiong J-B, et al.: Comparison of the effects of albumin and crystalloid on mortality among patients with septic shock: Systematic review with meta-analysis and trial sequential analysis. Sao Paulo Med J. 2018; 136:421–432.
Xu J-Y, Chen Q-H, Xie J-F, et al.: Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: A meta-analysis of randomized clinical trials. Crit Care. 2014; 18:702.
ClinicalTrials.gov: Albumin Replacement Therapy in Septic Shock (ARISS). 2021. Available at: https://clinicaltrials.gov/study/NCT03869385. Accessed May 29, 2024.
Shapiro NI, Douglas IS, Brower RG, et al.; National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network: Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023; 388:499–510.
Raynor B, Huang A, Udrea D, et al.: The role of albumin in the resuscitation of hypotensive patients. Curr Emerg Hosp Med Rep. 2023; 11:89–94.
La Via L, Vasile F, Perna F, et al.: Prediction of fluid responsiveness in critical care: Current evidence and future perspective. Trends Anaesth Crit Care. 2024; 54:101316.
Evans L, Rhodes A, Alhazzani W, et al.: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47:1181–1247.
Gray A, Oatey K, Grahamslaw J, et al.; Albumin, Balanced, and Crystalloid-Sepsis (ABC-Sepsis) Investigators: Albumin versus balanced crystalloid for the early resuscitation of sepsis: An open parallel-group randomized feasibility trial. The ABC-Sepsis trial. Crit Care Med. 2024; 52:1520–1532.
Legrand M, Pletcher MJ, Kim SYH: The need for change in generating evidence for the critically ill. Am J Respir Crit Care Med. 2023; 208:1156–1157.
Philips CA, Maiwall R, Sharma MK, et al.: Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): A randomized controlled trial. Hepatol Int. 2021; 15:983–994.
Park CHL, de Almeida JP, de Oliveira GQ, et al.: Lactated Ringer’s versus 4% albumin on lactated ringer’s in early sepsis therapy in cancer patients: A pilot single-center randomized trial. Crit Care Med. 2019; 47:e798–e805.
Maitland K, Kiguli S, Opoka RO, et al.; FEAST Trial Group: Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364:2483–2495.
No Comments.